SCHEMBL15063201

SCHEMBL15063201

O=C(CCCCl)NC(C(=O)O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 1/20 0.49
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.44
HPGD P15428 1/20 0.44
GAA P10253 1/20 0.44
ASAH1 Q13510 1/20 0.43
ACER2 Q5QJU3 1/20 0.43
FPR2 P25090 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 1/20 0.42
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
MAPT P10636 1/20 0.42
CTSG P08311 1/20 0.42
CMA1 P23946 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831553 0.85 NAALAD2 (0.50) NAALAD2ALDH1A1GAAASAH1ACER2
SCHEMBL3568607 0.84 NAALAD2 (0.49) NAALAD2ALDH1A1KMT2AATMASAH1
SCHEMBL3579475 0.84 NAALAD2 (0.49) NAALAD2ALDH1A1KMT2AATMASAH1
SCHEMBL11127543 0.83 ALDH1A1 (0.58) NAALAD2ALDH1A1SMN1; SMN2KMT2AATM
SCHEMBL28300956 0.83 ALDH1A1 (0.58) NAALAD2ALDH1A1SMN1; SMN2KMT2AATM
SCHEMBL31043494 0.83 ASAH1 (0.63) ALDH1A1ASAH1ACER2NPSR1
SCHEMBL31043495 0.83 ASAH1 (0.63) ALDH1A1ASAH1ACER2NPSR1
SCHEMBL22207714 0.81 NAALAD2 (0.60) NAALAD2ALDH1A1FPR2MAPT
SCHEMBL14842114 0.81 ASAH1 (0.66) ALDH1A1KMT2AASAH1ACER2NPSR1
SCHEMBL14842112 0.81 ASAH1 (0.66) ALDH1A1KMT2AASAH1ACER2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797910-B1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMA SPA (IT) 2015-09-16 EP disclosed
EP-2797910-B1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMA SPA (IT) 2015-09-16 EP disclosed
EP-2797910-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF Chiesi Farmaceutici S.p.A. (IT) 2014-11-05 EP disclosed
US-8748613-B2 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-06-10 US disclosed
US-8748613-B2 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-06-10 US disclosed
US-8748613-B2 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-06-10 US disclosed
US-20130172302-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-04 US disclosed
US-20130172302-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-04 US disclosed
US-20130172302-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-04 US disclosed
WO-2013098145-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-04 WO disclosed
WO-2013098145-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130172302-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHRM1, CHRM2, CHRM3 NAALAD2 309/4885ALDH1A1 189/4885SMN1; SMN2 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.